Dr. Panzara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Wave Life Sciences
733 Concord Ave
Cambridge, MA 02138Phone+1 617-949-2977- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1995 - 1998
Stanford University School of MedicineClass of 1994
Harvard School of Public HealthMasters in Public Health
Certifications & Licensure
MA State Medical License 1997 - 2026- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis Start of enrollment: 2001 Nov 01
- Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis Start of enrollment: 2002 Jan 01
- Open-Label Natalizumab Safety Extension Study Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.Alan J Thompson, Marcello Moccia, Maria Pia Amato, Peter A Calabresi, Marcia Finlayson, Annie Hawton, Fred D Lublin, Ruth Ann Marrie, Xavier Montalban, Michael Panzara...> ;Multiple Sclerosis. 2023 Oct 1
- 9 citationsBayesian adaptive design for clinical trials in Duchenne muscular dystrophy.Stephen L. Lake, Melanie Quintana, Kristine Broglio, Jennifer Panagoulias, Scott M. Berry, Michael Panzara> ;Statistics in Medicine. 2021 May 7
- 3 citationsGenotyping single nucleotide polymorphisms for allele-selective therapy in Huntington diseaseDaniel O. Claassen, Jody Corey-Bloom, E. Ray Dorsey, Mary Edmondson, Sandra K. Kostyk, Mark S. LeDoux, Ralf Reilmann, H. Diana Rosas, Francis O. Walker, Vicki L. Wheel...> ;Neurology. Genetics. 2020 Jun 1
- Join now to see all
Press Mentions
Hope in the Wake of Recent Failures in Huntington’s DiseaseAugust 17th, 2021- Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics DiscoveryMay 18th, 2020
Is It over for This Huntington’s Disease Clinical Trial?December 30th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
